Pharmacotherapy and psychotherapy of pediatric depression

Bibliography

• Harrington R. The natural history and treatment of child and adolescent affective disorders. J Child Psychol Psychiatry 1992;33(8):1287-302
   PubMedGoogle Scholar
• Fombonne E, Wostear G, Cooper V, The Maudsley long-term follow-up of child and adolescent depression. 2. Suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry 2001;179:218-23
   PubMed Web of Science ®Google Scholar
• Diagnostic and statistical manual of mental disorders. 4th edition- text revision edition. American Psychiatric Association, Arlington, VA; 2000
   Google Scholar
• Carlson GA, Cantwell DP. Unmasking masked depression in children and adolescents. Am J Psychiatry 1980;137(4):445-9
   PubMedGoogle Scholar
• Luby JL, Heffelfinger AK, Mrakotsky C, The clinical picture of depression in preschool children. J Am Acad Child Adolesc Psychiatry 2003;42(3):340-8
   PubMedGoogle Scholar
• Luby JL, Heffelfinger A, Mrakotsky C, Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry 2003;60(12):1248-55
   PubMedGoogle Scholar
• Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18(7):765-94
   PubMedGoogle Scholar
• Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 1990;29(4):571-80
   PubMedGoogle Scholar
• Brent DA. Correlates of the medical lethality of suicide attempts in children and adolescents. J Am Acad Child Adolesc Psychiatry 1987;26(1):87-91
   PubMedGoogle Scholar
• Pfeffer CR, Klerman GL, Hurt SW, Suicidal children grow up: demographic and clinical risk factors for adolescent suicide attempts. J Am Acad Child Adolesc Psychiatry 1991;30(4):609-16
   PubMedGoogle Scholar
• Kandel DB, Davies M. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry 1986;43(3):255-62
   PubMedGoogle Scholar
• Kovacs M, Feinberg TL, Crouse-Novak MA, Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 1984;41(3):229-37
   PubMedGoogle Scholar
• Rohde P, Lewinsohn PM, Seeley JR. Are adolescents changed by an episode of major depression? J Am Acad Child Adolesc Psychiatry 1994;33(9):1289-98
   PubMedGoogle Scholar
• Birmaher B, Ryan ND, Williamson DE, Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996;35(11):1427-39
   PubMed Web of Science ®Google Scholar
• Birmaher B, Brent D, Bernet W, Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46(11):1503-26
   PubMedGoogle Scholar
• Lewinsohn PM, Rohde P, Seeley JR, Psychosocial functioning of young adults who have experienced and recovered from major depressive disorder during adolescence. J Abnorm Psychol 2003;112(3):353-63
   PubMedGoogle Scholar
• Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996;35(6):705-15
   PubMedGoogle Scholar
• Kaufman J, Martin A, King RA, Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry 2001;49(12):980-1001
   PubMedGoogle Scholar
• Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 1994;33(4):461-8
   PubMedGoogle Scholar
• Martin A, Young C, Leckman JF, Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 2004;158(8):773-80
   PubMedGoogle Scholar
• Bridge JA, Iyengar S, Salary CB, Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297(15):1683-96
   PubMedGoogle Scholar
• Axelson DA, Perel JM, Birmaher B, Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. Am J Psychiatry 2005;162(4):802-4
   PubMedGoogle Scholar
• Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005;46(7):735-54
   PubMedGoogle Scholar
• Bridge JA, Birmaher B, Iyengar S, Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009;166(1):42-9
   PubMedGoogle Scholar
• Emslie GJ, Rush AJ, Weinberg WA, A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54(11):1031-7
   PubMedGoogle Scholar
• Emslie GJ, Heiligenstein JH, Wagner KD, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41(10):1205-15
   PubMedGoogle Scholar
• March J, Silva S, Petrycki S, Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292(7):807-20
   PubMedGoogle Scholar
• Keller MB, Ryan ND, Strober M, Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40(7):762-72
   PubMedGoogle Scholar
• Wagner KD, Ambrosini P, Rynn M, Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003;290(8):1033-41
   PubMedGoogle Scholar
• Wagner KD, Robb AS, Findling RL, A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161(6):1079-83
   PubMedGoogle Scholar
• von Knorring AL, Olsson GI, Thomsen PH, A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26(3):311-15
   PubMedGoogle Scholar
• Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009;48(7):721-9
   PubMedGoogle Scholar
• Wagner KD, Jonas J, Findling RL, A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45(3):280-8
   PubMedGoogle Scholar
• Brent D, Emslie G, Clarke G, Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008;299(8):901-13
   PubMed Web of Science ®Google Scholar
• Glod CA, Lynch A, Flynn E, Open trial of bupropion SR in adolescent major depression. J Child Adolesc Psychiatr Nurs 2003;16(3):123-30
   PubMedGoogle Scholar
• Arredondo DE. Bupropion treatment of adolescent depression. Annual Meeting of the American Psychiatric Association 1993; San Fransisco, CA; 1993
   Google Scholar
• Daviss WB, Bentivoglio P, Racusin R, Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 2001;40(3):307-14
   PubMedGoogle Scholar
• Daviss WB, Perel JM, Brent DA, Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study. Ther Drug Monit 2006;28(2):190-8
   PubMedGoogle Scholar
• Emslie GJ, Findling RL, Yeung PP, Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2007;46(4):479-88
   PubMedGoogle Scholar
• March J, Emslie G, Kratochvil C, An Open-Label Study of tolerability, safety, and pharmacokinetics of duloxetine in children (7-11 Years) and adolescents (12-17 Years) with MDD. 49th annual NCDEU Meeting; 2009; Hollywood, Florida; 2009
   Google Scholar
• Bangs ME, Emslie GJ, Spencer TJ, Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol 2007;17(4):407-20
   PubMedGoogle Scholar
• Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002(2):CD002317
   PubMedGoogle Scholar
• Nemets H, Nemets B, Apter A, Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006;163(6):1098-100
   PubMedGoogle Scholar
• Brent DA, Emslie GJ, Clarke GN, Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009;166(4):418-26
   PubMedGoogle Scholar
• Vitiello B, Silva SG, Rohde P, Suicidal events in the Treatment for Adolescents With Depression Study (TADS). J Clin Psychiatry 2009;70(5):741-7
   PubMedGoogle Scholar
• Emslie G, Kratochvil C, Vitiello B, Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006;45(12):1440-55
   PubMedGoogle Scholar
• Wilens TE, Wyatt D, Spencer TJ. Disentangling disinhibition. J Am Acad Child Adolesc Psychiatry 1998;37(11):1225-7
   PubMedGoogle Scholar
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352(11):1112-20
   PubMed Web of Science ®Google Scholar
• Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005;4(2):337-44
   PubMedGoogle Scholar
• Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 1997;58(7):291-7
   PubMedGoogle Scholar
• Compton SN, March JS, Brent D, Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004;43(8):930-59
   PubMedGoogle Scholar
• Harrington R, Campbell F, Shoebridge P, Whittaker J. Meta-analysis of CBT for depression in adolescents. J Am Acad Child Adolesc Psychiatry 1998;37(10):1005-7
   PubMedGoogle Scholar
• Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006;132(1):132-49
   PubMedGoogle Scholar
• Birmaher B, Brent DA, Kolko D, Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000;57(1):29-36
   PubMedGoogle Scholar
• Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 1996;37(6):737-46
   PubMedGoogle Scholar
• Kennard BD, Silva SG, Tonev S, Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009;48(2):186-95
   PubMedGoogle Scholar
• Goodyer I, Dubicka B, Wilkinson P, Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ 2007;335(7611):142
   PubMedGoogle Scholar
• Curry J, Rohde P, Simons A, Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45(12):1427-39
   PubMedGoogle Scholar
• Renaud J, Brent DA, Baugher M, Rapid response to psychosocial treatment for adolescent depression: a two-year follow-up. J Am Acad Child Adolesc Psychiatry 1998;37(11):1184-90
   PubMedGoogle Scholar
• Brent DA, Kolko DJ, Birmaher B, Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry 1998;37(9):906-14
   PubMedGoogle Scholar
• Rohde P, Clarke GN, Mace DE, An efficacy/effectiveness study of cognitive-behavioral treatment for adolescents with comorbid major depression and conduct disorder. J Am Acad Child Adolesc Psychiatry 2004;43(6):660-8
   PubMedGoogle Scholar
• Asarnow JR, Emslie G, Clarke G, Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009;48(3):330-9
   PubMedGoogle Scholar
• Barbe RP, Bridge JA, Birmaher B, Lifetime history of sexual abuse, clinical presentation, and outcome in a clinical trial for adolescent depression. J Clin Psychiatry 2004;65(1):77-83
   PubMedGoogle Scholar
• Garber J, Clarke GN, Weersing VR, Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA 2009;301(21):2215-24
   PubMedGoogle Scholar
• Clarke GN, Hornbrook M, Lynch F, A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry 2001;58(12):1127-34
   PubMedGoogle Scholar
• Klomek AB, Mufson L. Interpersonal psychotherapy for depressed adolescents. Child Adolesc Psychiatr Clin N Am 2006;15(4):959-75, ix
   PubMedGoogle Scholar
• Young JF, Mufson L, Davies M. Efficacy of interpersonal psychotherapy-adolescent skills training: an indicated preventive intervention for depression. J Child Psychol Psychiatry 2006;47(12):1254-62
   PubMedGoogle Scholar
• Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol 1999;67(5):734-45
   PubMedGoogle Scholar
• Rossello J, Bernal G, Rivera-Medina C. Individual and group CBT and IPT for Puerto Rican adolescents with depressive symptoms. Cultur Divers Ethnic Minor Psychol 2008;14(3):234-45
   PubMedGoogle Scholar
• Horowitz JL, Garber J, Ciesla JA, Prevention of depressive symptoms in adolescents: a randomized trial of cognitive-behavioral and interpersonal prevention programs. J Consult Clin Psychol 2007;75(5):693-706
   PubMedGoogle Scholar
• Kennard B, Silva S, Vitiello B, Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45(12):1404-11
   PubMed Web of Science ®Google Scholar
• March J, Silva S, Curry J, The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry 2009;166(10):1141-9
   PubMedGoogle Scholar
• Emslie GJ, Heiligenstein JH, Hoog SL, Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004;43(11):1397-405
   PubMedGoogle Scholar
• Tao R, Emslie G, Mayes T, Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry 2009;48(1):71-8
   PubMedGoogle Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006;354(12):1231-42
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Fava M, Wisniewski SR, Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354(12):1243-52
   PubMedGoogle Scholar
• Ryan ND, Meyer V, Dachille S, Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 1988;27(3):371-6
   PubMedGoogle Scholar
• Strober M, Freeman R, Rigali J, The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry 1992;31(1):16-20
   PubMedGoogle Scholar
• Cooper-Kazaz R, Apter JT, Cohen R, Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2007;64(6):679-88
   PubMedGoogle Scholar
• Papakostas GI, Cooper-Kazaz R, Appelhof BC, Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies. Int Clin Psychopharmacol 2009;24(1):19-25
   PubMedGoogle Scholar
• Emslie GJ, Mayes T, Porta G, Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry 2010; In press
   Google Scholar
• Ghaziuddin N, Kutcher SP, Knapp P, Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry 2004;43(12):1521-39
   PubMedGoogle Scholar
• Kronenberg S, Apter A, Brent D, Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol 2007;17(6):741-50
   PubMedGoogle Scholar
• Brent D, Melhem N, Ferrell R, Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 2010;167(2):190-7
   PubMedGoogle Scholar
• Emslie GJ, Rush AJ, Weinberg WA, Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety 1998;7(1):32-9
   PubMedGoogle Scholar
• Findling RL, McNamara NK, Stansbrey RJ, The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression. J Child Adolesc Psychopharmacol 2006;16(1-2):131-45
   PubMedGoogle Scholar
• Axelson DA, Perel JM, Birmaher B, Sertraline pharmacokinetics and dynamics in adolescents. J Am Acad Child Adolesc Psychiatry 2002;41(9):1037-44
   PubMedGoogle Scholar
• Sakolsky DJ, Emslie GJ, Clarke GN, Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study submitted; 2010
   Google Scholar
• De Cuyper S, Timbremont B, Braet C, Treating depressive symptoms in schoolchildren: a pilot study. Eur Child Adolesc Psychiatry 2004;13(2):105-14
   PubMedGoogle Scholar
• Weisz JR, Thurber CA, Sweeney L, Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. J Consult Clin Psychol 1997;65(4):703-7
   PubMedGoogle Scholar
• Luby JL. Early childhood depression. Am J Psychiatry 2009;166(9):974-9
   PubMedGoogle Scholar
• Celik G, Diler RS, Tahiroglu AY, Avci A. Fluoxetine in posttraumatic eating disorder in two-year-old twins. J Child Adolesc Psychopharmacol 2007;17(2):233-6
   PubMedGoogle Scholar
• Coskun M, Zoroglu S. Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2009;19(3):297-300
   PubMedGoogle Scholar
• Gleason MM, Egger HL, Emslie GJ, Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 2007;46(12):1532-72
   PubMedGoogle Scholar
• Maalouf FT, Porta G, Vitiello B, Trajectories of depressive symptom response in the Treatment of Resistant Depression in Adolescents (TORDIA) Study: a latent class analysis. 2010; In preparation
   Google Scholar
• Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009;166(9):980-91
   PubMed Web of Science ®Google Scholar
• Weissman MM, Pilowsky DJ, Wickramaratne PJ, Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006;295(12):1389-98
   PubMedGoogle Scholar
• Swartz HA, Frank E, Zuckoff A, Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry 2008;165(9):1155-62
   PubMedGoogle Scholar
• Goldstein BI, Shamseddeen W, Spirito A, Substance use and the treatment of resistant depression in adolescents. J Am Acad Child Adolesc Psychiatry 2009;48(12):1182-92
   PubMedGoogle Scholar
• Dunkin JJ, Leuchter AF, Cook IA, Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 2000;60(1):13-23
   PubMedGoogle Scholar
• Majer M, Ising M, Kunzel H, Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychol Med 2004;34(8):1453-63
   PubMedGoogle Scholar
• Mayberg HS, Brannan SK, Mahurin RK, Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8(4):1057-61
   PubMed Web of Science ®Google Scholar
• Chen CH, Ridler K, Suckling J, Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62(5):407-14
   PubMedGoogle Scholar
• Leuchter AF, Cook IA, Gilmer WS, Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 2009;169(2):132-8
   PubMedGoogle Scholar
• Siegle GJ. Neural mechanisms of executive control in unipolar depression: relationships to emotional reactivity and recovery in Cognitive Behavior Therapy. In: Weissman A, editor. Executive function: from basic research to clinical practice. Philadelphia, Pennsylvania: Symp Meet Assoc Behav Cogn 2007
   Google Scholar
• Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry 2009;66(6):633-9
   PubMedGoogle Scholar
• Gibbons RD, Brown CH, Hur K, Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164(9):1356-63
   PubMedGoogle Scholar
• Laje G, Paddock S, Manji H, Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 2007;164(10):1530-8
   PubMedGoogle Scholar
• Perlis RH, Purcell S, Fava M, Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 2007;64(6):689-97
   PubMedGoogle Scholar
• Berard R, Fong R, Carpenter DJ, An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006;16(1-2):59-75
   PubMedGoogle Scholar
• Emslie GJ, Wagner KD, Kutcher S, Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006;45(6):709-19
   PubMedGoogle Scholar
• Simeon JG, Dinicola VF, Ferguson HB, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990;14(5):791-5
   PubMedGoogle Scholar